Team:Wageningen UR/Achievements

From 2013.igem.org

(Difference between revisions)
 
(6 intermediate revisions not shown)
Line 58: Line 58:
     </div>
     </div>
     <div class="blok">
     <div class="blok">
-
         <img src="http://beauvillemedia.nl/igem/silver.png" alt="Silver">
+
         <img src="https://static.igem.org/mediawiki/2013/0/0b/Silver.png" alt="Silver">
         <h2>Silver medal</h2>
         <h2>Silver medal</h2>
         <div class="medalcontent">
         <div class="medalcontent">
Line 75: Line 75:
             <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023001">The pkiA promoter has successfully been used to express the ATP bio-sensor</a></p>
             <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023001">The pkiA promoter has successfully been used to express the ATP bio-sensor</a></p>
             <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023002">The xlnD terminator has successfully been used for the ATP bio-sensor</a></p>
             <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023002">The xlnD terminator has successfully been used for the ATP bio-sensor</a></p>
-
             <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023005">the codon optimized eforRed has successfully been used attached to a mitochondrial signal peptide and has given a red color to the mycellium of <i>Aspergillus niger</i></a></p>
+
             <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023005">The codon optimized eforRed has successfully been used attached to a mitochondrial signal peptide and has given a red color to the mycellium of <i>Aspergillus niger</i></a></p>
         </div>
         </div>
         <div class="medalcontent">
         <div class="medalcontent">
Line 81: Line 81:
             </div>
             </div>
         <div id="safety" class="hiddeninfo">
         <div id="safety" class="hiddeninfo">
-
             <p></p>
+
             <p class="dot"><a href="https://2013.igem.org/Team:Wageningen_UR/Parts">A material transfer agreement (MTA) is made to formalize the exchange of biological parts like cell-lines, plasmids and reagents and protect the rights of all the parties involved.</a></p>
         </div>
         </div>
     </div>
     </div>
     <div class="blok">
     <div class="blok">
-
         <img src="http://beauvillemedia.nl/igem/gold.png" alt="Gold">
+
         <img src="https://static.igem.org/mediawiki/2013/3/32/Goldmed.png" alt="Gold">
         <h2>Gold medal</h2>
         <h2>Gold medal</h2>
         <div class="medalcontent">
         <div class="medalcontent">
Line 120: Line 120:
</script>
</script>
</html>
</html>
 +
<!--- Header Template --->
<!--- Header Template --->
{{:Team:Wageningen_UR/Templates/Page Footer}}
{{:Team:Wageningen_UR/Templates/Page Footer}}

Latest revision as of 18:27, 23 April 2014

Achievements

Silver

Silver medal

Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected
info

Document the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry

Submit this new part to the iGEM Parts Registry
info

Your project may have implications for the environment, security, safety and ethics and/or ownership and sharing. Describe one or more ways in which these or other broader implications have been taken into consideration in the design and execution of your project
info

Gold

Gold medal

Improve the function of an existing BioBrick Part or Device, enter this information in the Registry, create a new registry page for the improved part, and submit this part to the iGEM Parts Registry
info

Help any registered iGEM team from another school or institution by, for example, characterizing a part, debugging a construct, or modeling or simulating their system
info

Your project may have implications for the environment, security, safety and ethics and/or ownership and sharing. Describe a novel approach that your team has used to help you and others consider these aspects of the design and outcomes of synthetic biology efforts. Please justify its novelty and how this approach might be adapted and scaled for others to use
info